The SNBL CPC vision is dynamically executed throughout every phase of the operationfrom the top down. Key leadership at SNBL CPC continues the successful tradition of parent company Shin Nippon Biomedical Laboratories, Ltd., Japan's largest and oldest CRO. Striving to offer the highest quality research services at every stage of the drug-development process, the SNBL CPC team brings a wealth of research experience and a collaborative spirit that uniquely positions the organization as a true champion for your pharmaceutical development initiatives.
Clinical Research Department
Mohamed S. Al-Ibrahim
Chief Medical Officer & President [CV-PDF]
Medical Director [CV-PDF]
Director of Operations [CV-PDF]
Client Service & Partnership
Vice President of Business Development
Director of Business Development
Chairman of SNBL Clinical Pharmacology Center, Inc.
CEO, SNBL Group Companies
Ryoichi Nagata, M.D., Ph.D., is the Chairman of SNBL Clinical
Pharmacology Center, Inc. He heads SNBL Global Group as CEO & President, which includes
serving as Chairman of SNBL USA, Ltd. (Everett, WA). [more...]
CEO of SNBL Clinical Pharmacology Center, Inc.
Takeshi Yamakawa, the CEO of SNBL Clinical Pharmacology Center, Inc., is in charge of strategic and daily corporate management of SNBL CPC, Inc. He developed business strategy and plans, and executed them to establish the growing business from the ground up. He has once again joined the SNBL Clinical Pharmacology Center team as CEO, and continues to provide creative and strategic vision to keep SNBL Clinical Pharmacology Center at the forefront of research clinics.[more...]